TopiVert news - the latest biotech news from Labiotech.eu

Home TopiVert

Latest Posts

topivert dry eye disease syndrome

News and Trends 7 Aug 2019

Late-Stage Clinical Trial Troubles for Dry Eye Disease Drug

A drug developed by the UK company Topivert Pharma has failed to reduce eyeball grittiness sensations in patients with dry eye disease in a phase II/III trial. The trial tested…

August 7, 2019 - 2 minutesmins - By Jonathan Smith

topivert ulcerative colitis trial

News and Trends 8 Jan 2018

Biotech in London Paves the Way for a New Therapy for Ulcerative Colitis

TopiVert has successfully completed a Phase I trial in ulcerative colitis with a new class of drug that could help reduce adverse side effects. The results of a Phase I…

January 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

dry eye syndrome topivert 1

News and Trends 8 Dec 2017

A London Biotech Aims to Overtake the Dry Eye Syndrome Market

TopiVert has released the results of a clinical trial that the company believes yielded "the best proof of concept data in dry eye syndrome." Based in London, the biotech company…

December 8, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Beyond Biotech - the podcast from Labiotech

View More

Newsletter Signup - Sidebar

"*" indicates required fields

Want to advertise with us?

Reach us here!

Got a news story for us?

Send it to us here